PI
BRLI

PineBridge Investments’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

PineBridge Investments’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,829
Closed -$117K – 1195
2015
Q2 		$117K Sell
2,829
-3,355
-54% -$120K ﹤0.01% 709
2015
Q1 		$218K Buy
6,184
+561
+10% +$19K 0.01% 711
2014
Q4 		$180K Buy
5,623
+236
+4% +$6.83K 0.01% 746
2014
Q3 		$152K Buy
5,387
+1,500
+39% +$45.7K 0.01% 740
2014
Q2 		$117K Sell
3,887
-2,110
-35% -$58.2K ﹤0.01% 731
2014
Q1 		$166K Sell
5,997
-555
-8% -$14.5K 0.01% 821
2013
Q4 		$168K Buy
6,552
+3,753
+134% +$116K 0.01% 844
2013
Q3 		$84K Hold
2,799
– – ﹤0.01% 777
2013
Q2 		$80K Buy
+2,799
New +$77.1K ﹤0.01% 784

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

PineBridge Investments's BRLI Position: Q3 2015 in Review

PineBridge Investments sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 2,829 shares — an estimated $117K sold.

PineBridge Investments first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $218K in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • PineBridge Investments reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • PineBridge Investments sold 2,829 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $117K.
  • PineBridge Investments first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • PineBridge Investments's BIO-REFERENCE LABS INC-NEW- position peaked at $218K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on PineBridge Investments's 13F filing for Q3 2015, filed 13 Nov 2015.